At a glance
ClinicalIndex Comparison RecordN/ACompleted· 47 enrolled
Drug / intervention
Tibetan Meditation Program +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feasibility Study of Meditation, Cognitive Function, and Quality of Life in Women With Breast Cancer
In Brief
A clinical study evaluating Tibetan Meditation Program and No Meditation for Breast Cancer. Completed, enrolled 47 participants across 1 site.
Detailed Summary
The goal of this behavioral research study is to learn if participating in a Tibetan meditation program helps to improve quality of life for women after chemotherapy and during recovery from breast cancer. Whether the meditation program helps to improve brain function and sleep quality will also be studied.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2007
First PostedNov 2007
Primary CompletionAug 2022
TodayJul 2026
First PostedNov 9, 2007
Enrollment StartOct 24, 2007
Primary CompletionAug 10, 2022
TodayJul 1, 2026
Enrollment to primary: 14.8 yearsPosted 18.6 years ago
Interventions
Tibetan Meditation Programbehavioral
12 sessions of Tibetan meditation (2 times a week), over a 6-week period. Each class will last about 60 minutes.
No Meditationbehavioral
No meditation; usual care.